NEU 3.15% $21.27 neuren pharmaceuticals limited

Hotcopper tends to destroy your formatting when you post. Have...

  1. 369 Posts.
    lightbulb Created with Sketch. 1094
    Hotcopper tends to destroy your formatting when you post. Have tried to repost the tables I included below in a more readable format.

    Hashan's POS from Table 4 of his article

    Phelan-McDermid:

    Phase III

    30%

    1

    Angelman:

    Phase II

    15%

    2

    Pitt-Hopkins:

    Phase II

    15%

    3

    Prader-Willi:

    Phase II

    10%


    Comparing patient numbers from Hashan vs Neuren.

    Hashan

    Neuren

    1

    Phelan-McDermid

    40k

    24k

    2

    Angelman

    27k

    19k

    3

    Pitt-Hopkins

    29k

    6k

    4

    Prader-Willi

    32k

    17k


    Comparing POS from Hashan vs published research.

    Phase

    Table 4

    90-95% disc

    Wong et al (2019) MIT

    1

    Phelan-McDermid

    Phase III

    30%

    5%-10%

    32%

    2

    Angelman

    Phase II

    15%

    5%-10%

    8.3%

    3

    Pitt-Hopkins

    Phase II

    15%

    5%-10%

    8.3%

    4

    Prader-Willi

    Phase II

    10%

    5%-10%

    8.3%

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$21.27
Change
0.650(3.15%)
Mkt cap ! $2.718B
Open High Low Value Volume
$20.84 $21.56 $20.76 $7.760M 364.5K

Buyers (Bids)

No. Vol. Price($)
2 1378 $21.24
 

Sellers (Offers)

Price($) Vol. No.
$21.29 218 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.